RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS

      Association between Inflammatory Bowel Disease and Lactose Intolerance: Fact or Fiction

      한글로보기

      https://www.riss.kr/link?id=A107092098

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Background/Aims: Inflammatory bowel disease (IBD) is a complex condition precipitated by genetic susceptibility and possibly a disturbed microbiome. The role of dairy foods in IBD is controversial. This study examined the association between lactose i...

      Background/Aims: Inflammatory bowel disease (IBD) is a complex condition precipitated by genetic susceptibility and possibly a disturbed microbiome. The role of dairy foods in IBD is controversial. This study examined the association between lactose intolerance (LI) and IBD.
      Methods: Data on hospital admissions of all IBD adult patients were extracted from the National Inpatient Sample database between 2004 and 2014. The comorbidities and outcomes of interest were defined by querying all the diagnostic and procedural fields for the corresponding International Classification of Diseases 9th version (ICD-9) codes. Patients with IBD were defined as the “study group,” and the patients who did not have IBD were defined as the “control group”. LI was identified in both groups using the ICD-9 codes. Multivariate logistic regression was performed to examine the association between IBD and LI.
      Results: The total population was 71,342,237 patients, of which 598,129 (0.83%) had IBD. The IBD patients were younger (52 years vs. 57 years) and with fewer females (57.5% vs. 60.1%) (p<0.001 for all). After adjusting for the potential confounding factors, the IBD group had a significantly higher rate of LI (OR 2.71, 95% CI 2.55-2.88, p<0.001) compared to the non-IBD group. The findings were similar on the further stratification of IBD into Crohn’s disease compared to the control group (OR 2.70, 95% CI 2.50-2.92, p<0.001) and ulcerative colitis compared to the control group (OR 2.71, 95% CI 2.46-2.98, p<0.001).
      Conclusions: IBD patients have a 2.7 times higher risk of LI. Screening for LI in this population is warranted to avoid confusing or overlapping symptomatology.

      더보기

      참고문헌 (Reference)

      1 Szilagyi A, "Systematic review and meta-analysis of lactose digestion, its impact on intolerance and nutritional effects of dairy food restriction in inflammatory bowel diseases" 15 : 67-, 2016

      2 Kappelman MD, "Recent trends in the prevalence of Crohn’s disease and ulcerative colitis in a commercially insured us population" 58 : 519-525, 2013

      3 Kirschner BS, "Lactose malabsorption in children and adolescents with inflammatory bowel disease" 81 : 829-832, 1981

      4 Misselwitz B, "Lactose malabsorption and intolerance : pathogenesis, diagnosis and treatment" 1 : 151-159, 2013

      5 Hüppe D, "Lactose intolerance in chronic inflammatory bowel diseases" 117 : 1550-1555, 1992

      6 Deng Y, "Lactose intolerance in adults : biological mechanism and dietary management" 7 : 8020-8035, 2015

      7 Mattar R, "Lactose intolerance : diagnosis, genetic, and clinical factors" 5 : 113-121, 2012

      8 M'Koma AE, "Inflammatory bowel disease : an expanding global health problem" 6 : 33-47, 2013

      9 Mishkin B, "Increased prevalence of lactose malabsorption in Crohn's disease patients at low risk for lactose malabsorption based on ethnic origin" 92 : 1148-1153, 1997

      10 Gudmand-Hoyer E, "Incidence and clinical significance of lactose malabsorption in ulcerative colitis and Crohn’s disease" 11 : 338-343, 1970

      1 Szilagyi A, "Systematic review and meta-analysis of lactose digestion, its impact on intolerance and nutritional effects of dairy food restriction in inflammatory bowel diseases" 15 : 67-, 2016

      2 Kappelman MD, "Recent trends in the prevalence of Crohn’s disease and ulcerative colitis in a commercially insured us population" 58 : 519-525, 2013

      3 Kirschner BS, "Lactose malabsorption in children and adolescents with inflammatory bowel disease" 81 : 829-832, 1981

      4 Misselwitz B, "Lactose malabsorption and intolerance : pathogenesis, diagnosis and treatment" 1 : 151-159, 2013

      5 Hüppe D, "Lactose intolerance in chronic inflammatory bowel diseases" 117 : 1550-1555, 1992

      6 Deng Y, "Lactose intolerance in adults : biological mechanism and dietary management" 7 : 8020-8035, 2015

      7 Mattar R, "Lactose intolerance : diagnosis, genetic, and clinical factors" 5 : 113-121, 2012

      8 M'Koma AE, "Inflammatory bowel disease : an expanding global health problem" 6 : 33-47, 2013

      9 Mishkin B, "Increased prevalence of lactose malabsorption in Crohn's disease patients at low risk for lactose malabsorption based on ethnic origin" 92 : 1148-1153, 1997

      10 Gudmand-Hoyer E, "Incidence and clinical significance of lactose malabsorption in ulcerative colitis and Crohn’s disease" 11 : 338-343, 1970

      11 Ananthakrishnan A, "Environmental triggers in IBD : a review of progress and evidence" 15 : 39-49, 2018

      12 Mishkin S, "Dairy sensitivity, lactose malabsorption, and elimination diets in inflammatory bowel disease" 65 : 564-567, 1997

      13 Mishkin, S, "Dairy sensitivity, lactose malabsorption, and elimination diets in inflammatory bowel disease" 65 : 564-567, 1997

      14 Halmos EP, "Consistent prebiotic effect on gut microbiota with altered FODMAP intake in patients with Crohn's disease : a randomised, controlled cross-over trial of well-defined diets" 7 : e164-, 2016

      15 Barrett JS, "Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders" 30 : 165-174, 2009

      16 Peyrin-Biroulet L, "Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn’s disease in the SONIC trial" 63 : 88-95, 2014

      17 Eadala P, "Association of lactose sensitivity with inflammatory bowel disease--demonstrated by analysis of genetic polymorphism, breath gases and symptoms" 34 : 735-746, 2011

      18 Sairenji T, "An update on inflammatory bowel disease" 44 : 673-692, 2017

      19 Wright R, "A controlled therapeutic trial of various diets in ulcerative colitis" 2 : 138-141, 1965

      20 Furnari M, "A comparison between lactose breath test and quick test on duodenal biopsies for diagnosing lactase deficiency in patients with self-reported lactose intolerance" 47 : 148-152, 2013

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2022 평가예정 재인증평가 신청대상 (재인증)
      2019-01-01 평가 등재학술지 유지 (계속평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2002-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1999-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.18 0.18 0.18
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.21 0.2 0.315 0.03
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼